FIELD: medicine.
SUBSTANCE: invention relates to the use of 1-{[6-bromo-1-methyl-5-methoxy-2-phenylthiomethyl-1-H-indol-3-yl]carbonyl}-4-benzylpiperazine hydrochloride as membrane stabilizing agent for the prevention and treatment of diseases of the bronchopulmonary system.
EFFECT: invention provides an expansion of the arsenal of agents that simultaneously have a pronounced virus-specific effect and a membrane-stabilizing property.
2 cl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
CLATHRATE COMPLEXES OF BETA-CYCLODEXTRIN WITH 1-{[6-BROMO-1-METHYL-5-METHOXY-2-PHENYLTHIOMETHYL-1-H-INDOL-3-YL]CARBONYL}-4-BENZYLPIPERAZINE, HAVING ANTIVIRAL ACTIVITY, SYNTHESIS AND USE THEREOF | 2010 |
|
RU2448120C1 |
MEDICATION AGAINST B INFLUENZA VIRUS | 2010 |
|
RU2435582C1 |
5-SUBSTITUTED INDOLE-3-CARBOXYLIC ACID DERIVATIVES, HAVING ANTIVIRAL ACTIVITY, SYNTHESIS METHOD THEREOF AND USE | 2007 |
|
RU2387642C2 |
INTERFERON-INDUCING AGENT FOR TREATING ACUTE RESPIRATORY VIRAL INFECTIONS (ARVD) | 2010 |
|
RU2445094C1 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVES HAVING ANTIVIRAL ACTIVITY | 2013 |
|
RU2552422C2 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVE HAVING ANTIVIRAL ACTIVITY ON SARS-CoV-2 | 2022 |
|
RU2820633C1 |
ONCOGENIC RAS-SPECIFIC CYTOTOXIC COMPOUND AND METHODS FOR USING IT | 2006 |
|
RU2448703C2 |
ARYL UREA DERIVATIVES AS N-FORMILEPEPTIDE-1 RECEPTOR (FPRL-1) MODULATORS | 2012 |
|
RU2627271C2 |
DERIVATIVES OF 5-HYDROXY-4-AMINOMETHYL-1-CYCLOHEXYL (OR CYCLOHEPTYL)-3-ALKOXYCARBONYLINDOLES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, HAVING ANTIVIRAL ACTIVITY AND METHOD OF PRODUCING SAID COMPOUNDS | 2008 |
|
RU2386616C2 |
DERIVATIVE OF 1-[(INDOLE-3-YL)CARBONYL]PIPERAZINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND ITS USING | 2003 |
|
RU2318821C2 |
Authors
Dates
2023-04-11—Published
2021-08-16—Filed